Cargando…
Opportunities for multiscale computational modelling of serotonergic drug effects in Alzheimer's disease
Alzheimer's disease (AD) is an age-specific neurodegenerative disease that compromises cognitive functioning and impacts the quality of life of an individual. Pathologically, AD is characterised by abnormal accumulation of beta-amyloid (Aβ) and hyperphosphorylated tau protein. Despite research...
Autores principales: | Joshi, Alok, Wang, Da-Hui, Watterson, Steven, McClean, Paula L., Behera, Chandan K., Sharp, Trevor, Wong-Lin, KongFatt |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pergamon Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7322519/ https://www.ncbi.nlm.nih.gov/pubmed/32380022 http://dx.doi.org/10.1016/j.neuropharm.2020.108118 |
Ejemplares similares
-
Toward a multiscale modeling framework for understanding serotonergic function
por: Wong-Lin, KongFatt, et al.
Publicado: (2017) -
Functions and computational principles of serotonergic and related systems at multiple scales
por: Nakamura, Kae, et al.
Publicado: (2014) -
Degeneracy and stability in neural circuits of dopamine and serotonin neuromodulators: A theoretical consideration
por: Behera, Chandan K., et al.
Publicado: (2023) -
Multi-dimensional relationships among dementia, depression and prescribed drugs in England and Wales hospitals
por: Joshi, Alok, et al.
Publicado: (2022) -
Alzheimer's disease classification using cluster‐based labelling for graph neural network on heterogeneous data
por: McCombe, Niamh, et al.
Publicado: (2022)